The Pancreatic Cancer Action Network has engaged five new clinical trial sites in the US, which will aid in evaluation of Novartis’ investigational therapy.
Researchers from the Oncology Department of Tianjin Medical University Cancer Hospital in China recently published a study in Advanced Functional Materials announcing the creation of a new nano-carrier for pancreatic cancer treatments.
Shares in US biotech ImClone Systems fell on Tuesday after a
highly-anticipated trial of its cancer drug Erbitux (cetuximab) in
pancreatic cancer failed to live up to expectations.
US researchers have developed the first animal model that clearly
defines cancer metastasises in all the same places that human
pancreatic cancer spreads to such as the liver, lungs, diaphragm,
and adrenal glands.
Austrian biotech company, Austrianova, has received approval from
the European Medicines Evaluation Agency (EMEA) for its product
Novacaps, a new category of therapeutic for pancreatic cancer.
EMEA's latest decision ensures trial...
